EMD Serono Research & Development Institute

NCT04551950

Phase 1Completed202025 people16 Sept 2020clinicaltrials.gov

NCT04459715

Phase 3Terminated2020730 people7 Jul 2020clinicaltrials.gov

NCT04066491

Phase 2/3Terminated2019309 people26 Aug 2019clinicaltrials.gov

NCT03840902

Phase 2Terminated2019153 people15 Feb 2019clinicaltrials.gov

NCT03116971

Phase 1Terminated20172 people17 Apr 2017clinicaltrials.gov

NCT02576574

Phase 3Completed20151,214 people15 Oct 2015clinicaltrials.gov

NCT02516813

Phase 1Completed201552 people6 Aug 2015clinicaltrials.gov

NCT02157792

Phase 1Completed2012200 people6 Jun 2014clinicaltrials.gov